Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Particella, Inc. logo — company profile

Particella, Inc.

Founded 2016 United States San Francisco, United States 4 employees Convertible Note Biotechnology

General Information

Company Name Particella, Inc.
Founded Year 2016
Location United States San Francisco, United States
Employees 4
Industries Biotechnology
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Particella, Inc.. To contact Particella, Inc., visit particella.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Particella, Inc. compare?

A PDF of Particella, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Particella, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Particella, Inc.

Particella, Inc. is a biotechnology company that has developed a novel proprietary lipid nanoparticle for oral delivery of mRNA and other nucleic acids. Founded in 2016 and headquartered in the United States, the company received a Convertible Note investment from SOSV and indiebio on 07 March 2023. With its innovative technology, Particella, Inc. is poised to make significant strides in the biotechnology industry.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Undisclosed 2
SOSV indiebio
SOSV, indiebio
07 Mar 2023
Seed Round Undisclosed 1
SeedFolio
SeedFolio
01 Jan 2020

Particella, Inc. Alternatives & Competitors

View All Alternatives
Particella, Inc. vs
DNALite Therapeutics
DNALite Therapeutics

Pioneering oral therapies for intestinal delivery of mRNA and pDNA, transforming proteins into oral...

Convertible Note
Biotechnology, Health Care
Particella, Inc. vs
Providence Therapeutics
Providence Therapeutics Canada

Where Hope and Science Intersect

56 employees
Biotechnology, Health Care
Particella, Inc. vs
Pantherna Therapeutics GmbH
Pantherna Therapeutics GmbH Germany

Developing novel mRNA-based therapeutics

Seed
11 employees
Biotechnology, Health Care
View all alternatives

FAQ About Particella, Inc.

Particella Inc., (formerly DNAlite Therapeutics) is a biotechnology company that has developed a novel proprietary lipid nanoparticle that can deliver mRNA and other nucleic acids orally.
Particella, Inc. was founded in 2016.
Particella, Inc. is headquartered in San Francisco, United States.
Particella, Inc. operates in Biotechnology.
Particella, Inc. has approximately 4 employees.
Particella, Inc. has completed 2 funding rounds. The latest funding stage is Convertible Note.
Top alternatives and competitors to Particella, Inc. include DNALite Therapeutics, Providence Therapeutics, Pantherna Therapeutics GmbH, Gennao Bio, 4basebio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Particella, Inc. and DNALite Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Particella, Inc., https://bouncewatch.com/company/particella-inc, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout